“…Also, our approach was able to highlight compounds, such as tamoxifen, loratadine, and https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2334, where none of the models (not even the CiPA 1.0 model) were able to fit the data satisfactorily. On closer inspection (Supporting Information) the data of loratadine, and nitrendipine showed a slight increase of the (percentage) current over time during the 0 m V pulses, raising potential data quality issues (Lei, Clerx, et al, 2020; Montnach et al, 2021; Raba, et al, 2013) or the need for methods to account for inadequacy of the models (Lei, Ghosh, et al, 2020; Lei & Mirams, 2021) and/or new (un)binding mechanisms to explain this observation; whilst for tamoxifen, there was a more obvious data quality issue for one of the concentrations. In Figure S26, we also included the results of fitting all the binding models whilst assuming the Hill coefficient (number of binding sites) to be .…”